Prognostic Factors Analysis in Patients with Hepatocellular Carcinoma Receiving PD-1/PD-L1 Inhibitors
Journal of Hepatocellular Carcinoma · 2026-08 · Volume 13 · 1-20
DOI: 10.2147/jhc.s623481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-08. Verfasst von Yubin Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, Peo…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, People's Republic of China.
- Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310020, People's Republic of China.
ORCID-Profile: Da Li
Zitieren
APA
Pan, Y., Li, Q., Tang, H., Chen, G., & Li, D. (2026). Prognostic Factors Analysis in Patients with Hepatocellular Carcinoma Receiving PD-1/PD-L1 Inhibitors. Journal of Hepatocellular Carcinoma, Volume 13, 1-20. https://doi.org/10.2147/jhc.s623481
Vancouver
Pan Y, Li Q, Tang H, Chen G, Li D. Prognostic Factors Analysis in Patients with Hepatocellular Carcinoma Receiving PD-1/PD-L1 Inhibitors. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-20. doi:10.2147/jhc.s623481
BibTeX
@article{Pan2026,
author = {Pan, Yubin and Li, Qijun and Tang, Honglin and Chen, Guangpeng and Li, Da},
title = {Prognostic Factors Analysis in Patients with Hepatocellular Carcinoma Receiving PD-1/PD-L1 Inhibitors},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--20},
doi = {10.2147/jhc.s623481}
}
EUVIMED